Finch Therapeutics Group Inc

NASDAQ:FNCH  
13.33
+0.11 (+0.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Finch Therapeutics Group Inc Stock, NASDAQ:FNCH

200 Inner Belt Road, Suite 400, Somerville, Massachusetts 02143
United States of America
Phone: +1.617.229.6499
Number of Employees: 131000

Description

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in September 2017 and is headquartered in Somerville, MA.